BREAKING NEWS

Oxford to study popular prescription drug as potential COVID-19 treatment

By REUTERS

SEPTEMBER 30, 2020 12:21

Britain's Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients, the latest effort to repurpose existing drugs as potential coronavirus therapies.

The AVID-CC trial will test the anti-tumor necrosis factor (anti-TNF) drug and will be aimed at treating people in the community, especially in care homes. It will enroll up to 750 patients from community care settings throughout the UK.

Rocket sirens sound in Nahariya, northern Israel

By JERUSALEM POST STAFF

11/05/2024 05:22 PM

Trump: Kamala will start WW3, get millions of Muslims killed

By JERUSALEM POST STAFF

11/05/2024 01:10 PM

Putin tells Western diplomats Russia is committed to cooperation

By REUTERS

11/05/2024 01:08 PM

Germany says Iran is responsible for death of Sharmahd

By REUTERS

11/05/2024 12:33 PM